Mechanisms of simvastatin-induced vasodilatation of rat superior mesenteric arteries

Biomedical Reports

Volumn 5, Issue 4, 2016, Pages 491-496

  Chen, Yulong ^a,b   Zhang, Hongmei ^b   Liu, Huanhuan ^b   Cao, Ailan ^a,c  

^a Shaanxi Pharmaceutical Holding Group Co   (China)

^b XI'AN MEDICAL UNIVERSITY   (China)

^c Shaanxi University of Traditional Chinese Medicine   (China)

Author keywords

Ca2+ influxs; K+ channel; Nitric oxide; Simvastatin; Vasorelaxant effects

Indexed keywords

SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; MALE; MYOGRAPHY; NONHUMAN; RAT; SUPERIOR MESENTERIC ARTERY; VASODILATATION;

EID: 85044199757     PISSN: 20499434     EISSN: 20499442     Source Type: Journal    
DOI: 10.3892/br.2016.756     Document Type: Article

References (18)

1. Pedersen TR, Wilhelmsen L, Faergeman O, Strandberg TE, Thorgeirsson G, Troedsson L, Kristianson J, Berg K, Cook TJ, Haghfelt T, et al: Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol 86: 257-262, 2000.
2. Alvarez De Sotomayor M, Herrera MD, Marhuenda E and Andriantsitohaina R: Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat. Br J Pharmacol 131: 1179-1187, 2000.
3. Mauro VF and MacDonald JL: Simvastatin: A review of its pharmacology and clinical use. DICP 25: 257-264, 1991.
4. Gryn SE and Hegele RA: Ezetimibe plus simvastatin for the treatment of hypercholesterolemia. Expert Opin Pharmacother 16: 1255-1262, 2015.
5. Robinson JG: Simvastatin: Present and future perspectives. Expert Opin Pharmacother 8: 2159-27, 2007.
6. Jiang JL, Jiang DJ, Tang YH, Li NS, Deng HW and Li YJ: Effect of simvastatin on endothelium-dependent vaso-relaxation and endogenous nitric oxide synthase inhibitor. Acta Pharmacol Sin 25: 893-901, 2004.
7. Cao YX, Zhang W, He JY, He LC and Xu CB: Ligustilide induces vasodilatation via inhibiting voltage dependent calcium channel and receptor-mediated Ca2+ influx and release. Vascul Pharmacol 45: 171-176, 2006.
8. Zhu XM, Fang LH, Li YJ and Du GH: Endothelium-dependent and-independent relaxation induced by pinocembrin in rat aortic rings. Vascul Pharmacol 46: 160-165, 2007.
9. Rubanyi GM: The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 22 (Suppl 4): S1-S14, 1993.
10. Nelson MT and Quayle JM: Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268: C799-C822, 1995.
11. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ and Cohen RA: Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853, 1994.
12. Brayden JE: Potassium channels in vascular smooth muscle. Clin Exp Pharmacol Physiol 23: 1069-1076, 1996.
13. Vergara C, Latorre R, Marrion NV and Adelman JP: Calcium-activated potassium channels. Curr Opin Neurobiol 8: 321-329, 1998.
14. Horowitz A, Menice CB, Laporte R and Morgan KG: Mechanisms of smooth muscle contraction. Physiol Rev 76: 967-1003, 1996.
15. Hirata S, Enoki T, Kitamura R, Vinh VH, Nakamura K and Mori K: Effects of isoflurane on receptor-operated Ca2+ channels in rat aortic smooth muscle. Br J Anaesth 81: 578-583, 1998.
16. Lee CH, Poburko D, Sahota P, Sandhu J, Ruehlmann DO and van Breemen C: The mechanism of phenylephrine-mediated [Ca(2+)](i) oscillations underlying tonic contraction in the rabbit inferior vena cava. J Physiol 534: 641-650, 2001.
17. Lee CN, Wong KL, Liu JC, Chen YJ, Cheng JT and Chan P: Inhibitory effect of stevioside on calcium influx to produce antihypertension. Planta Med 67: 796-799, 2001.
18. Eckert RE, Karsten AJ, Utz J and Ziegler M: Regulation of renal artery smooth muscle tone by alpha1-adrenoceptors: Role of voltage-gated calcium channels and intracellular calcium stores. Urol Res 28: 122-127, 2000.